What target do you utilize in clinical practice for defining disease remission in RA?
This question is part of a collaboration with RheumMadness and is specifically in reference to:
Answer from: at Academic Institution
Clinical trials have consistently shown that a treat-to-target strategy in RA achieves better outcomes than "usual care". In 2019, The American College of Rheumatology recommended four in particular: Rapid 3, DAS 28 ESR or CRP, CDAI or SDAI. Several years ago, our EMR IT team (EPIC) incorporated the...
Sign in or Register to read more